文献速递白血病

二代测序提升Ph阳性急性淋巴细胞白血病BCR-ABL1突变检测

Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2021-01-06

本研究在171例Ph阳性急性淋巴细胞白血病患者中比较Sanger测序与二代测序检测BCR-ABL1激酶域突变。

要点

  • NGS较Sanger测序在TKI治疗的Ph+ ALL中检出更多BCR-ABL1突变。
  • NGS可识别复合突变并解析克隆复杂性。

研究设计与样本

  • 连续纳入171例Ph+ ALL患者,比较Sanger测序与NGS检测BCR-ABL1突变的结果。

主要发现

  • 诊断时Sanger测序0/44阳性,NGS 3/44阳性。
  • 47例血液学耐药患者中,两种方法均检出45例突变,NGS在25例中额外检出Sanger测序未发现的突变。
  • 12例Sanger测序阳性患者中NGS检出额外突变。
  • NGS在34例同一位点或不同位点多突变患者中解析克隆复杂性,并鉴定35个复合突变。

临床怎么用

  • 对TKI耐药的Ph+ ALL患者,NGS可提高BCR-ABL1突变检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BCR-ABL1 kinase domain mutation testing in tyrosine kinase inhibitor (TKI)-resistant Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia (ALL) patients is routinely performed by Sanger sequencing (SS). Recently, next-generation sequencing (NGS)-based approaches have been developed that afford greater sensitivity and straightforward discrimination between compound and polyclonal mutations. We performed a study to compare the results of SS and NGS in a consecutive cohort of 171 Ph+ ALL patients. At diagnosis, 0/44 and 3/44 patients were positive for mutations by SS and NGS respectively. Out of 47 patients with haematologic resistance, 45 had mutations according to both methods, but in 25 patients NGS revealed additional mutations undetectable by SS. Out of 80 patients in complete haematologic response but with BCR-ABL1 ≥0·1%, 28 (35%) and 52 (65%) were positive by SS and NGS respectively. Moreover, in 12 patients positive by SS, NGS detected additional mutations. NGS resolved clonal complexity in 34 patients with multiple mutations at the same or different codons and identified 35 compound mutations. Our study demonstrates that, in Ph+ ALL on TKI therapy, NGS enables more accurate assessment of mutation status both in patients who fail therapy and in patients with minimal residual disease above 0·1%.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Soverini S, Martelli M, Bavaro L, et al. Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia. Br J Haematol. 2021. PMID: 33403687. doi:10.1111/bjh.17301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。